Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non-Current Deffered Revenue (2020 - 2021)

Historic Non-Current Deffered Revenue for Cullinan Therapeutics (CGEM) over the last 2 years, with Q4 2021 value amounting to $65000.0.

  • Cullinan Therapeutics' Non-Current Deffered Revenue fell 1216.22% to $65000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $65000.0, marking a year-over-year decrease of 1216.22%. This contributed to the annual value of $65000.0 for FY2021, which is 1216.22% down from last year.
  • Cullinan Therapeutics' Non-Current Deffered Revenue amounted to $65000.0 in Q4 2021, which was down 1216.22% from $67000.0 recorded in Q3 2021.
  • Cullinan Therapeutics' 5-year Non-Current Deffered Revenue high stood at $74000.0 for Q4 2020, and its period low was $65000.0 during Q4 2021.